ArticleCancer research2024

Targeting BCL2 with Venetoclax Enhances the Efficacy of the KRASG12D Inhibitor MRTX1133 in Pancreatic Cancer.

Jeffrey H Becker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.